REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
12/22/2025
Back to search
Official data from USPTO
ACLARIS THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
50
Latest update
12/23/2025
Trademark type
Combined
Nice classes
5, 42
Filing date
12/06/2018
Registration date
12/22/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/22/2020
Last transaction
12/23/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
10/31/2018
First use in commerce
10/31/2018
Drawing code
3
Owner type
03
Owner location
Wayne, PA
Examiner
RADEMACHER,APRIL LUEDERS
Law office
L80
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of lower case letters "ACLARIS" centered over smaller capital letters"THERAPEUTICS", which are placed over on the right side of a partial circle design comprised of five segmented curved lines.
Holders and representatives
Holders
Aclaris Therapeutics, Inc.
Representatives
Michael A. Geller DLA Piper LLP (US)
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of dermatological diseases and disorders
Class 42
Research and development of pharmaceutical preparationsproducts and technology in the fields of dermatology; providing medical and scientific research information in the fields of dermatologypharmaceuticals and clinical trials; drug discovery services
Publications
History of USPTO decisions and trademark events.
50 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/02/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/02/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/02/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
11/02/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
11/02/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
12/22/2020
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
11/17/2020
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
11/16/2020
SUPC
STATEMENT OF USE PROCESSING COMPLETE
10/26/2020
IUAF
USE AMENDMENT FILED
10/16/2020
EISU
TEAS STATEMENT OF USE RECEIVED
10/16/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
08/18/2020
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
07/20/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
06/01/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/01/2020
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
06/01/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/01/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/01/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
06/01/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05/26/2020
EX1G
SOU EXTENSION 1 GRANTED
05/23/2020
EXT1
SOU EXTENSION 1 FILED
05/23/2020
EEXT
SOU TEAS EXTENSION RECEIVED
05/23/2020
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
11/26/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/01/2019
PUBO
PUBLISHED FOR OPPOSITION
10/01/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/11/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/27/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/24/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/23/2019
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
08/23/2019
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
06/04/2019
GNFR
FINAL REFUSAL E-MAILED
06/04/2019
CNFR
FINAL REFUSAL WRITTEN
06/04/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/13/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/13/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/13/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/21/2019
GNRT
NON-FINAL ACTION E-MAILED
02/21/2019
CNRT
NON-FINAL ACTION WRITTEN
02/21/2019
DOCK
ASSIGNED TO EXAMINER
02/14/2019
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
12/28/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/27/2018
TAEA
TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
12/21/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/21/2018
ALIE
ASSIGNED TO LIE
12/19/2018
ALIE
ASSIGNED TO LIE
12/18/2018
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
12/13/2018
NWAP
NEW APPLICATION ENTERED
12/10/2018
Continuous trademark protection
Get notified about every new filing that threatens ACLARIS THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.